Minimizing delays to hemodialysis access maturation: A quality improvement analysis

Article Properties
  • Language
    English
  • Publication Date
    2024/04/11
  • Indian UGC (journal)
  • Refrences
    18
  • Andrew S Warren Division of Vascular Surgery, University of Washington, Seattle, WA, USAPacific Northwest University of Health Sciences, Yakima, WA, USA ORCID (unauthenticated)
  • Hannah Wolf Division of Vascular Surgery, University of Washington, Seattle, WA, USA
  • Charles J Hillenbrand Division of Vascular Surgery, University of Washington, Seattle, WA, USA
  • Gale L Tang Division of Vascular Surgery, University of Washington, Seattle, WA, USAVA Puget Sound Health Care System, Seattle, WA, USA
Abstract
Cite
Warren, Andrew S, et al. “Minimizing Delays to Hemodialysis Access Maturation: A Quality Improvement Analysis”. The Journal of Vascular Access, 2024, https://doi.org/10.1177/11297298241244509.
Warren, A. S., Wolf, H., Hillenbrand, C. J., & Tang, G. L. (2024). Minimizing delays to hemodialysis access maturation: A quality improvement analysis. The Journal of Vascular Access. https://doi.org/10.1177/11297298241244509
Warren, Andrew S, Hannah Wolf, Charles J Hillenbrand, and Gale L Tang. “Minimizing Delays to Hemodialysis Access Maturation: A Quality Improvement Analysis”. The Journal of Vascular Access, 2024. https://doi.org/10.1177/11297298241244509.
Warren AS, Wolf H, Hillenbrand CJ, Tang GL. Minimizing delays to hemodialysis access maturation: A quality improvement analysis. The Journal of Vascular Access. 2024;.
Refrences
Title Journal Journal Categories Citations Publication Date
La inhibición de la interleucina-6 como posible diana terapéutica en la amiloidosis AA Nefrología
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the genitourinary system. Urology
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the genitourinary system. Urology
  • Medicine: Medicine (General)
1 2022
La inhibición de la interleucina-6 como posible diana terapéutica en la amiloidosis AA 2021
La inhibición de la interleucina-6 como posible diana terapéutica en la amiloidosis AA JBR Journal of Clinical Diagnosis and Research 2015
La inhibición de la interleucina-6 como posible diana terapéutica en la amiloidosis AA 1993
Mortality benefits of different hemodialysis access types are age dependent Journal of Vascular Surgery
  • Medicine: Surgery
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
  • Medicine: Medicine (General)
56 2015